Original articleTrends in incidence of adult-onset psoriasis over three decades: A population-based study
Introduction
Psoriasis is a common systemic inflammatory disorder affecting primarily the skin, nails, and occasionally the joints. The prevalence of psoriasis in different populations varies between 0 and 12%,1 with estimates as high as 2.8% in western populations.2, 3 Apart from differences in study populations, the wide variation in prevalence estimates may be due to the remitting relapsing course of psoriasis, wide spectrum in clinical presentation and severity, and, most importantly, lack of standardized classification criteria.4
Studies on the incidence of psoriasis are rare, mostly because of the same limiting factors. Two incidence studies covering different time frames were reported from Olmsted County, Minnesota. Bell et al5 reported an incidence of 60.4 (95% confidence interval [CI]: 49.5-70.3) per 100,000 person-years between 1980 and 1983. Shbeeb et al6 screened all psoriasis cases between 1982 and 1991 and reported an incidence of 107.7 (95% CI: 101.2-114.2) per 100,000. More recently, in a large database study from the United Kingdom, the incidence of psoriasis in the period 1996-1997 was estimated as 140 per 100,000 patient years.7 Intriguingly, the results of these 3 reports from different time periods suggest an increase in the incidence of psoriasis over time. Yet, no studies to date examined trends in incidence of psoriasis.
The objective of this population-based study was to describe time trends in incidence, characteristics, and survival of psoriasis patients in Olmsted County, Minnesota between 1970 and 2000.
Section snippets
Study setting
This population-based retrospective study was carried out in Olmsted County, Minnesota, which has a population of 124,277 according to the 2000 census. We used the resources of the Rochester Epidemiology Project,8 a medical records linkage system containing complete inpatient and outpatient records from all healthcare providers in Olmsted County, including the Mayo Clinic, Olmsted Medical Group, local nursing homes, and the few private practitioners. All medical, surgical, and histological
Results
We identified a total of 3105 potential subjects with diagnostic codes consistent with psoriasis between January 1, 1970 and January 1, 2000. After the complete medical records from all healthcare providers were screened, 1633 (52.6%) psoriasis subjects fulfilled criteria for inclusion in the incidence cohort. Of the 1472 excluded subjects, 64.8% had diagnoses other than psoriasis (eg, parapsoriasis, pityriasis rosea, psoriasiform dermatitis) and 35.2% were prevalent subjects (ie, psoriasis
Discussion
In this population-based study, we describe trends in incidence of psoriasis over time and demonstrate, for the first time, that the incidence of psoriasis increased significantly over the 3 decades between 1970 and 2000. The reasons for this increase in incidence are unknown, but could include a variety of factors, including a true change in incidence or changes in the diagnosing patterns in this population. Our findings also indicate that the age- and sex-specific incidence of psoriasis is in
References (42)
History of the Rochester Epidemiology Project
Mayo Clin Proc
(1996)Psoriasis: future research needs and goals for the twenty-first century
Dermatol Clin
(2004)- et al.
Potential misclassification of psoriasis patients in electronic databases
J Am Acad Dermatol
(2008) - et al.
Psoriasis: epidemiology
Clin Dermatol
(2007) - et al.
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study
J Invest Dermatol
(2005) - et al.
Drugs in exacerbation of psoriasis
J Am Acad Dermatol
(1986) - et al.
The epidemiology of obesity
Gastroenterology
(2007) - et al.
Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction
Am Heart J
(2005) - et al.
Prevalence and secular trends of excess body weight and impact on outcomes after myocardial infarction in the community
Chest
(2004) - et al.
Evidence-based therapies for myocardial infarction: secular trends and determinants of practice in the community
Mayo Clin Proc
(2004)
Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris
J Am Acad Dermatol
Miscellaneous diseases affected by pregnancy
Clin Dermatol
Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients
J Invest Dermatol
Psoriasis
N Engl J Med
Epidemiology of psoriasis
Curr Drug Targets Inflamm Allergy
Epidemiology: natural history and genetics
The diagnosis of psoriasis: diagnostic criteria
Br J Dermatol
Incidence of psoriasis in Rochester, Minn, 1980-1983
Arch Dermatol
Incidence of psoriasis and psoriatic arthritis, a population-based study
Arthritis Rheum
Incidence and risk factors for psoriasis in the general population
Arch Dermatol
A SAS macro which utilizes local and reference population counts appropriate for incidence, prevalence, and mortality rate calculations in Rochester and Olmsted County, Minnesota. Technical Report Series
Cited by (211)
Unmet needs in the management of psoriasis in Latin America: a systematic review
2024, Anais Brasileiros de DermatologiaAge at Natural Menopause, Reproductive Lifespan, and the Risk of Late-Onset Psoriasis and Psoriatic Arthritis in Women: A Prospective Cohort Study
2024, Journal of Investigative DermatologyLigustrazine alleviates psoriasis-like inflammation through inhibiting TRAF6/c-JUN/NFκB signaling pathway in keratinocyte
2022, Biomedicine and PharmacotherapyCitation Excerpt :Psoriasis is a chronic immune-mediated skin disease which is prevalent in about 2–3% of the world’s population [1]. The incidence of psoriasis also has a trend of continuous increase [2,3]. Of the various phenotypes, psoriasis vulgaris is the most common one.
Population-based incidence of psoriasis vulgaris in Germany: analysis of national statutory insurance data from 65 million population
2024, Archives of Dermatological ResearchPsoriasis and Fibromyalgia: A Systematic Review
2024, Journal of Personalized Medicine
Supported by an unrestricted research grant from Amgen Inc and AR30582 from NIAMS.
Disclosure: Dr Kremers has received consulting fees, speaking fees, and/or honoraria (less than $10,000) from Amgen. Dr Dann is a former Amgen employee, holds Amgen stock, and has a consultancy agreement with Amgen. Drs Icen, Crowson, McEvoy, and Gabriel declared no conflicts of interest.